Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Angel Lanas

Showing results (61-70 of 270) with videos related to

Pageof 27
Sort By:
Expert Opinion on Pharmacotherapy|April 7, 2023
Advances in the pharmacotherapeutic management of refractory peptic ulcersCristina Borao Laguna, Angel Lanas
Journal of Digestive Diseases|December 11, 2012
Is NSAIDs-related gastrointestinal damage preventable?Carla J Gargallo, Angel Lanas
Gastroenterologia Y Hepatologia|March 26, 2014
Genetic susceptibility and gastric cancer risk: the importance of meta-analyses as a statistical toolMaría Asunción García-González, Angel Lanas
The Open Rheumatology Journal|January 20, 2015
Monitoring complete blood counts and haemoglobin levels in osteoarthritis patients: results from a European survey investigating primary care physician behaviours and understandingChris Walker, Augusto Faustino, Angel Lanas
Journal of Clinical Biochemistry and Nutrition|July 19, 2011
European physicians don't like cytoprotective agents?Takashi Kawai, Angel Lanas, Shinya Goto
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|September 3, 2010
Cost-effectiveness of colorectal cancer screening in high-risk Spanish patients: use of a validated model to inform public policyUri Ladabaum, Angel Ferrandez, Angel Lanas
Lancet (London, England)|March 1, 2017
Peptic ulcer diseaseAngel Lanas, Francis K L Chan
Inflammopharmacology|August 21, 2023
Comparison of gastrointestinal adverse events between fast release tablets and regular acetylsalicylic acid (aspirin) galenics after short-term use: a meta-analysis of randomized clinical trialsAngel Lanas, Oliver Werz, Engy Mikhail
Atencion Primaria|February 10, 2016
[NSAID and gastrointestinal risk]Beatriz Marcén, Carlos Sostres, Angel Lanas
Annals of the Rheumatic Diseases|December 20, 2013
Gastrointestinal events in at-risk patients starting non-steroidal anti-inflammatory drugs (NSAIDs) for rheumatic diseases: the EVIDENCE study of European routine practiceAngel Lanas, Maarten Boers, Javier Nuevo
Pageof 27

Showing results (61-70 of 270) with videos related to

Sort By:
Pageof 27
Expert Opinion on Pharmacotherapy|April 7, 2023
Advances in the pharmacotherapeutic management of refractory peptic ulcersCristina Borao Laguna, Angel Lanas
Journal of Digestive Diseases|December 11, 2012
Is NSAIDs-related gastrointestinal damage preventable?Carla J Gargallo, Angel Lanas
Gastroenterologia Y Hepatologia|March 26, 2014
Genetic susceptibility and gastric cancer risk: the importance of meta-analyses as a statistical toolMaría Asunción García-González, Angel Lanas
The Open Rheumatology Journal|January 20, 2015
Monitoring complete blood counts and haemoglobin levels in osteoarthritis patients: results from a European survey investigating primary care physician behaviours and understandingChris Walker, Augusto Faustino, Angel Lanas
Journal of Clinical Biochemistry and Nutrition|July 19, 2011
European physicians don't like cytoprotective agents?Takashi Kawai, Angel Lanas, Shinya Goto
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|September 3, 2010
Cost-effectiveness of colorectal cancer screening in high-risk Spanish patients: use of a validated model to inform public policyUri Ladabaum, Angel Ferrandez, Angel Lanas
Lancet (London, England)|March 1, 2017
Peptic ulcer diseaseAngel Lanas, Francis K L Chan
Inflammopharmacology|August 21, 2023
Comparison of gastrointestinal adverse events between fast release tablets and regular acetylsalicylic acid (aspirin) galenics after short-term use: a meta-analysis of randomized clinical trialsAngel Lanas, Oliver Werz, Engy Mikhail
Atencion Primaria|February 10, 2016
[NSAID and gastrointestinal risk]Beatriz Marcén, Carlos Sostres, Angel Lanas
Annals of the Rheumatic Diseases|December 20, 2013
Gastrointestinal events in at-risk patients starting non-steroidal anti-inflammatory drugs (NSAIDs) for rheumatic diseases: the EVIDENCE study of European routine practiceAngel Lanas, Maarten Boers, Javier Nuevo
Pageof 27